Chatterjee NA, Cheng RK. Cardiovascular disease and COVID-19 : implications for prevention , surveillance and treatment. British Med Journal. 2020;106 (15): 1119–21.
Choi GJ, Kim HM, Kang H. The Potential Role of Dyslipidemia in COVID- 19 Severity : an Umbrella Review of Systematic Reviews. Journal of Lipid and Atherosclerosis. 2020; 9 (3): 435–48.
Poznyak AV, Bezsonov EE, Eid AH, Popkova TV, Nedosugova LV, Starodubova AV. et al. ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis,” International Journal of Molecular Science. 2021; 22 (9): 1–11.
Reihani H, Shamloo AS and Keshmiri A. Diagnostic Value of D-Dimer in Acute Myocardial Infarction Among Patients With Suspected Acute Coronary Syndrome. Cardiology Research. 2018; 9 (1): 17–21.
Weitz JI, Fredenburgh JC, Eikelboom JW. A Test in Context: D-Dimer. Journal of the American College of Cardiology. 2020; 70 (19): 2411–2420.
Sayer G. and Griffin JM. COVID-19 and Cardiovascular Disease. Circulation. 2019: 1648–55.
Perrin N, Iglesias JF, Rey F, Benzakour L, Cimci M, Noble S. et al. Impact of the COVID-19 pandemic on acute coronary syndromes. Swiss Med Wkly. 2020; 150: w20448.
Kudo N, Tanaka A, Ishii H, Uemura Y, Takagi K, Iwama M, et al. Prevalence of acute coronary syndrome during the pandemic of COVID-19 in the Tokai Region of Japan. Nagoya J Med Sci. 2021; 83 (4): 697-703.
Kunutsor SK. and Laukkanen JA. Cardiovascular Complications In COVID-19: A Systematic Review And Meta-Analysis. Journal of Infection. 2020; 81: E139-E141
Tam CCF, Siu D, Tse HF. COVID-19 and Acute Coronary Syndrome: Lessons for Everyone, Lancet. 2022; 19: 100346.
Ain NU, Saeed TB, Sajjad S, Mustafa A, Naeem MZ, Javed HMF. et al. Prevalence of Acute coronary syndrome (ACS) in COVID-19 affected patients in public hospital facility of Pakistan, a retrospective study COVID-19 association with ACS. International Journal of Scientific & Engineering Research. 2021; 12 (11): 1131-1148.
Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, Abosalif KOA, Ahmed Z, Younas S. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020; 13. (12): 1833-1839.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395: 1054-1062
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX. et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020; 382: 1708–1720
Teixeira R, Santos M, Gil V. COVID-19 and cardiovascular comorbidities: An update. Revista Portuguesa De Cardiologia. 2020; 39 (8): 417–9.
Esposito L, Cancro FP, Silverio A, Di Maio M, Iannece P, Damato A. et al. COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives. Oxid Med Cell Longev. 2021: 4936571.
Lunardi M, Mylotte D, Serruys P, Wijns W. The global effect of Covid-19 on acute coronary syndromes management. Eur Heart J. 2021; 42 (1): 724.1361.
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F. et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5 (1): 802-810.
Townsend L, Fogarty H, Dyer A, Martin-Loeches I, Bannan C, Nadarajan P. et al. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J Thromb Haemost. 2021; 4: 1064-1070.
Du WN, Zhang Y, Yu Y, Zhang RM. D-dimer levels is associated with severe COVID-19 infections: A meta-analysis. Int J Clin Pract. 2021; 75 (8): e14031.
Cameli M, Pastore MC, Mandoli GE, D'Ascenzi F, Focardi M, Biagioni G. et al. COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications. Front Cardiovasc Med. 2021; 7: 593496.
Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020; 14 (3): 247-250.
Varikasuvu SR, Varshney S, Dutt N, Munikumar M, Asfahan S, Kulkarni PP. et al. D-dimer, disease severity, and deaths (3D-study) in patients with COVID-19: a systematic review and meta-analysis of 100 studies. Sci Rep. 2021; 11: 21888.
Rostami M, Mansouritorghabeh H. 2020. D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol. 2020; 13 (11): 1265-1275.
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020; 368: 1091.
Yendrapalli U, Mullen S, Elawad A, Green JL. Impact of the COVID-19 pandemic on gender disparities in acute coronary syndrome patterns. Int J Cardiol Heart Vasc. 2022; 41: 101077.
Dessie ZG. and Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021; 21: 855.
Albitar O, Ballouze R, Ooi JP, Sheikh Ghadzi SM. Risk factors for mortality among COVID‐19 patients. Diabetes Res Clin Pract. 2020; 166: 108293.
Barbero U, Moncalvo C, Trabattoni D. Gender differences in acute coronary syndromes patterns during the COVID-19 outbreak. Am J Cardiovasc Dis. 2020; 10 (4): 506-513